Benjamin Shaker - 14 Sep 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Markets Officer
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Sep 2021
Transactions value $
-$2,043,044
Form type
4
Filing time
15 Sep 2021, 17:21:31 UTC
Next filing
04 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $73K +73K +64.28% $1.00* 187K 14 Sep 2021 Direct F1
transaction AGL Common Stock Sale -$2.12M -73K -39.13% $28.98 114K 14 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -73K -16.23% $0.00 377K 14 Sep 2021 Common Stock 73K $1.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 These options were granted on December 30, 2016, and became fully vested as of January 12, 2021.